Identification of a predictive biomarker for the beneficial effect of a Kampo (Japanese traditional) medicine keishibukuryogan in rheumatoid arthritis patients.
Ogawa K, Kojima T, Matsumoto C, Kamegai S, Oyama T, Shibagaki Y, Muramoto H, Kawasaki T, Fujinaga H, Takahashi K, Hikiami H, Goto H, Kiga C, Koizumi K, Sakurai H, Shimada Y, Yamamoto M, Terasawa K, Takeda S, Saiki I.
Ogawa K, et al. Among authors: yamamoto m.
Clin Biochem. 2007 Oct;40(15):1113-21. doi: 10.1016/j.clinbiochem.2007.06.005. Epub 2007 Jul 3.
Clin Biochem. 2007.
PMID: 17673196
Clinical Trial.